Screener/Healthcare/Biotechnology

APLS

Apellis Pharmaceuticals, Inc.NASDAQ
$17.27-0.29 (-1.68%)
Mid CapUnder $20HealthcareFastest GrowingLow BetaMost Profitable
$16.10
$30.48
$16.84
$17.46
EPS (TTM)$0.31
P/E Ratio55.73
Dividend Yield—
Market Cap$2.55B
Volume1.38M
Prev Close$17.57
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$458.6M$215.7M$1.67—47.0%
Q2 '25$178.5M-$42.2M$-0.33—-23.6%
Q1 '25$166.8M-$92.2M$-0.74—-55.3%
Q4 '24$212.5M-$36.4M$-0.29—-17.1%
Q3 '24$196.8M-$57.4M$-0.46—-29.2%
Q2 '24$199.7M-$37.7M$-0.30—-18.9%
Q1 '24$172.3M-$66.4M$-0.54—-38.5%
Q4 '23$146.4M-$88.6M$-0.72—-60.5%
Get Your Daily Market Recap